2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis (†)

Amyloid light chain (AL) amyloidosis is characterized by misfolded light chain (LC) (amyloid) deposition in various peripheral organs, leading to progressive dysfunction and death. There are no regulatory agency–approved treatments for AL amyloidosis, and none of the available standard of care appro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Amyloid
Auteurs principaux: Renz, Mark, Torres, Ronald, Dolan, Philip J., Tam, Stephen J., Tapia, Jose R., Li, Lauri, Salmans, Joshua R., Barbour, Robin M., Shughrue, Paul J., Nijjar, Tarlochan, Schenk, Dale, Kinney, Gene G., Zago, Wagner
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152553/
https://ncbi.nlm.nih.gov/pubmed/27494229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2016.1205974
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires